Unjoni Ewropea -
Malti -
EMA (European Medicines Agency)
insulin aspart sanofi
sanofi winthrop industrie - insulin aspart - diabetes mellitus - drogi użati fid-dijabete - insulin aspart sanofi is indicated for the treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.
Unjoni Ewropea -
Malti -
EMA (European Medicines Agency)
ryzodeg
novo nordisk a/s - insulina aspart, l-insulina degludec - diabetes mellitus - drogi użati fid-dijabete - trattament tad-dijabete mellitus f'adulti, adolexxenti u tfal mill-età ta 'sentejn.
Unjoni Ewropea -
Malti -
EMA (European Medicines Agency)
truvelog mix 30
sanofi winthrop industrie - insulin aspart - diabetes mellitus - drogi użati fid-dijabete - truvelog mix 30 is indicated for treatment of diabetes mellitus in adults, adolescents and children aged 10 years and above.
Unjoni Ewropea -
Malti -
EMA (European Medicines Agency)
fiasp
novo nordisk a/s - insulin aspart - diabetes mellitus - drugs used in diabetes, insulins and analogues for injection, fast-acting - trattament tad-dijabete mellitus f'adulti, adolexxenti u tfal ta 'sena u aktar.
Unjoni Ewropea -
Malti -
EMA (European Medicines Agency)
novomix
novo nordisk a/s - insulin aspart - diabetes mellitus - drogi użati fid-dijabete - trattament tad-dijabete mellitus.
Unjoni Ewropea -
Malti -
EMA (European Medicines Agency)
novorapid
novo nordisk a/s - insulin aspart - diabetes mellitus - drogi użati fid-dijabete - novorapid huwa indikat għat-trattament tad-dijabete mellitus f'adulti, adoloxxenti u tfal ta 'sena u aktar.
Unjoni Ewropea -
Malti -
EMA (European Medicines Agency)
kirsty (previously kixelle)
biosimilar collaborations ireland limited - insulin aspart - diabetes mellitus - drogi użati fid-dijabete - kirsty is indicated for treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.
Unjoni Ewropea -
Malti -
EMA (European Medicines Agency)
insulin human winthrop
sanofi-aventis deutschland gmbh - insulin human - diabetes mellitus - drogi użati fid-dijabete - dijabete mellitus fejn huwa meħtieġ it-trattament bl-insulina. insulina bniedem winthrop mgħaġġla huwa wkoll adattat għat-trattament ta ' koma hyperglycaemic u ketoacidosis, kif ukoll għall-kisba minn qabel, intra - u postoperative stabbilizzazzjoni fil-pazjenti bl-diabetes mellitus.
Unjoni Ewropea -
Malti -
EMA (European Medicines Agency)
insulin lispro sanofi
sanofi winthrop industrie - insulina lispro - diabetes mellitus - drogi użati fid-dijabete - għat-trattament ta 'adulti u tfal b'dijabete mellitus li jeħtieġu l-insulina għall-manteniment ta' omeostasi normali tal-glukożju. insulin lispro sanofi huwa indikat ukoll għall-istabbilizzazzjoni inizjali tad-dijabete mellitus.
Unjoni Ewropea -
Malti -
EMA (European Medicines Agency)
actraphane
novo nordisk a/s - insulin human - diabetes mellitus - drogi użati fid-dijabete - trattament tad-dijabete mellitus.